Article citationsMore >>

Ghahestani SM, Mahmoudi J, Hajebrahimi S, et al. Bradykinin as a probable aspect in SARS-CoV-2 scenarios: is bradykinin sneaking out of our sight? Iran J Allergy Asthma Immunol. 2020; 19(S1): 13-17.

has been cited by the following article:

Article

Cutaneous Manifestations in COVID-19 “Long Haulers”: Is This A Part of the Multisystem Inflammatory Syndrome?

1Private Practice, Oral, Maxillofacial and Reconstructive Surgery, Aiea, Hawaii, 96701

2Professor of Surgery, Temple University, Kornberg School of Dentistry, Philadelphia, PA, 19140


American Journal of Infectious Diseases and Microbiology. 2021, Vol. 9 No. 2, 48-50
DOI: 10.12691/ajidm-9-2-3
Copyright © 2021 Science and Education Publishing

Cite this paper:
Cameron Y. S. Lee. Cutaneous Manifestations in COVID-19 “Long Haulers”: Is This A Part of the Multisystem Inflammatory Syndrome?. American Journal of Infectious Diseases and Microbiology. 2021; 9(2):48-50. doi: 10.12691/ajidm-9-2-3.

Correspondence to: Cameron  Y. S. Lee, Private Practice, Oral, Maxillofacial and Reconstructive Surgery, Aiea, Hawaii, 96701. Email: CLee555294@aol.com

Abstract

The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a multisystem inflammatory syndrome that affects many different organs of the body. Extrapulmonary cutaneous manifestations are now being reported in greater frequency as occurring before or after onset of clinical symptoms. To the authors knowledge, there are few, if any published study that has documented the persistent cutaneous manifestations in patients who have recovered from COVID-19. In this report, we describe some of the cutaneous manifestations in patients known as COVID-19 “long haulers”.

Keywords